Cathay Biotech (SH:688065) Xin Lang Cai Jing·2025-08-22 03:11Company Overview - Kasei Biotech Co., Ltd. is located at 396 Lane 11, Oasis Ring Road, Minhang District, Shanghai, established on November 24, 2000, and listed on August 12, 2020 [1] - The company specializes in synthetic biology and related fields, classified under the basic chemical industry, specifically in chemical products and other chemical products [1] Stock Performance - As of August 22, Kasei Biotech's stock price increased by 2.01%, reaching 51.70 CNY per share, with a trading volume of 64.04 million CNY and a turnover rate of 0.22%, resulting in a total market capitalization of 37.29 billion CNY [1] - Year-to-date, the stock price has risen by 34.63%, with a 5-day increase of 5.34%, a 20-day increase of 6.62%, and a 60-day increase of 9.67% [1] Financial Performance - For the period from January to June 2025, Kasei Biotech reported a revenue of 1.671 billion CNY, reflecting a year-on-year growth of 15.68% [2] - The company has distributed a total of 1.023 billion CNY in dividends since its A-share listing, with 503 million CNY distributed over the past three years [2] Shareholder Information - As of June 30, 2025, Kasei Biotech had 11,700 shareholders, a decrease of 2.87% from the previous period, with an average of 49,801 circulating shares per shareholder, an increase of 2.95% [2] - Among the top ten circulating shareholders, the Huaxia SSE Sci-Tech Innovation Board 50 ETF (588000) ranked as the eighth largest shareholder, holding 19.85 million shares, an increase of 3.46 million shares from the previous period [2]